Search

everythinglearnresearchcommunity

for

Search:↓

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Placental mesenchymal stem cells and their conditioned medium significantly improve healing in local radiation injuries.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Low iron levels may be linked to some types of hair loss in women.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.